As of 2024-12-14, the Relative Valuation of Evolent Health Inc (EVH) is (31.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.38 USD, the upside of Evolent Health Inc based on Relative Valuation is -375.3%.
The range of the Relative Valuation is (22.74) - (31.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.7x - 53.5x | 49.9x |
| Forward P/E multiples | 27.7x - 51.6x | 51.2x |
| Fair Price | (22.74) - (31.95) | (31.33) |
| Upside | -299.8% - -380.8% | -375.3% |
| Date | P/E |
| 2024-12-12 | -18.40 |
| 2024-12-11 | -19.28 |
| 2024-12-10 | -18.44 |
| 2024-12-09 | -17.86 |
| 2024-12-06 | -17.99 |
| 2024-12-05 | -18.15 |
| 2024-12-04 | -18.57 |
| 2024-12-03 | -18.90 |
| 2024-12-02 | -20.51 |
| 2024-11-29 | -20.85 |
| 2024-11-27 | -20.87 |
| 2024-11-26 | -21.40 |
| 2024-11-25 | -19.70 |
| 2024-11-22 | -18.15 |
| 2024-11-21 | -18.70 |
| 2024-11-20 | -18.25 |
| 2024-11-19 | -19.28 |
| 2024-11-18 | -19.93 |
| 2024-11-15 | -19.98 |
| 2024-11-14 | -20.45 |
| 2024-11-13 | -20.57 |
| 2024-11-12 | -23.30 |
| 2024-11-11 | -24.42 |
| 2024-11-08 | -21.56 |
| 2024-11-07 | -39.65 |
| 2024-11-06 | -39.97 |
| 2024-11-05 | -38.03 |
| 2024-11-04 | -37.70 |
| 2024-11-01 | -37.86 |
| 2024-10-31 | -37.68 |
| 2024-10-30 | -38.95 |
| 2024-10-29 | -37.55 |
| 2024-10-28 | -38.10 |
| 2024-10-25 | -38.76 |
| 2024-10-24 | -36.74 |
| 2024-10-23 | -36.15 |
| 2024-10-22 | -37.05 |
| 2024-10-21 | -37.42 |
| 2024-10-18 | -38.63 |
| 2024-10-17 | -40.28 |
| 2024-10-16 | -42.81 |
| 2024-10-15 | -42.59 |
| 2024-10-14 | -43.78 |
| 2024-10-11 | -43.67 |
| 2024-10-10 | -43.25 |
| 2024-10-09 | -42.39 |
| 2024-10-08 | -41.36 |
| 2024-10-07 | -41.76 |
| 2024-10-04 | -42.50 |
| 2024-10-03 | -42.20 |